Stocks Health care MBOT
NASDAQ · Health careMicrobot Medical Inc. (MBOT)
It posted a net loss of $16.3M. In fiscal 2025 capital spending exceeded operating cash flow by $13.1M. At June 30, 2026 it held $3.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 11, 2026.
Key facts about Microbot Medical Inc.
- Net worth
- Microbot Medical Inc. has a market value (market cap) of $73.9M at the latest share price, and shareholders' equity of $68.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
- Cash flow
- In fiscal 2025 operations used $13M of cash.
- Latest report
- The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 11, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR
- Next earnings report
- Microbot Medical Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
What Microbot Medical Inc. does
Microbot Medical Inc. is registered with the SEC under industry code SIC 3841 (Surgical & Medical Instruments & Apparatus). Its shares trade on NASDAQ under the ticker MBOT.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | n/a | -$13.1M | -$0.29 | -$13.1M |
| 2024 | n/a | -$11.4M | -$0.73 | -$8.9M |
| 2023 | n/a | -$10.7M | -$1.05 | -$8.6M |
| 2022 | n/a | -$13.2M | -$1.81 | -$11.6M |
| 2021 | n/a | -$11.3M | -$1.59 | -$9.4M |
| 2020 | n/a | -$9.2M | -$1.29 | -$7.3M |
Earnings: every quarter and the next report date
Full financial statements: income, balance sheet and cash flow
Latest SEC filings
What Microbot Medical Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- October 6, 2026
- September 28, 2026
- August 11, 2026
- August 11, 2026
- August 7, 2026
- July 21, 2026
- July 7, 2026
- June 30, 2026
- June 25, 2026
- June 23, 2026
Insider trades
What the people running Microbot Medical Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
Who owns MBOT
Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.
5% holders
| Holder | Of class | Filed |
|---|---|---|
| Mitchell P. Kopin13G, passive with 2 related filers | 8.2% | January 23, 2026 |
Largest institutional holders
Insiders
Questions about MBOT
What does Microbot Medical Inc. do?
Microbot Medical Inc. is a company in the Health care sector, listed on NASDAQ as MBOT. Its shares trade on NASDAQ under the ticker MBOT.
What is Microbot Medical Inc.'s net worth?
Microbot Medical Inc. has a market value (market cap) of $73.9M at the latest share price, and shareholders' equity of $68.9M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.
Is Microbot Medical Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $16.3M.
When did Microbot Medical Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 11, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the investor disclosure from October 6, 2026.
When is Microbot Medical Inc.'s next earnings report?
Microbot Medical Inc.'s next report was expected around November 9, 2026 and is not on file with the SEC yet.
Similar companies
Compare MBOT with
Follow MBOT
Get an email when Microbot Medical Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Where the numbers come from
Financial figures are the values Microbot Medical Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.